SK287969B6 - Method to culture circovirus - Google Patents

Method to culture circovirus Download PDF

Info

Publication number: SK287969B6
Authority: SK; Slovakia
Prior art keywords: mammalian; adenovirus; circovirus; porcine; function
Prior art date: 2001-03-27

Application number

SK1210-2003A

Other languages

English (en)

Slovak (sk)

Other versions

SK12102003A3 (sk

Inventor

Qiang Liu

Suresh K. Tikoo

Philip Willson

Lorne A. Babiuk

Original Assignee

University Of Saskatchewan

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-27

Filing date

2002-03-27

Publication date

2012-08-06

2002-03-27 Application filed by University Of Saskatchewan filed Critical University Of Saskatchewan

2004-05-04 Publication of SK12102003A3 publication Critical patent/SK12102003A3/sk

2012-08-06 Publication of SK287969B6 publication Critical patent/SK287969B6/sk

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10041—Use of virus, viral particle or viral elements as a vector
- C12N2750/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10051—Methods of production or purification of viral material
- C12N2750/10052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Virology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

SK1210-2003A 2001-03-27 2002-03-27 Method to culture circovirus SK287969B6 (sk)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US27917301P	2001-03-27	2001-03-27
PCT/CA2002/000413 WO2002077210A2 (en)	2001-03-27	2002-03-27	Methods to culture circovirus

Publications (2)

Publication Number	Publication Date
SK12102003A3 SK12102003A3 (sk)	2004-05-04
SK287969B6 true SK287969B6 (sk)	2012-08-06

Family

ID=23067939

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK1210-2003A SK287969B6 (sk)	2001-03-27	2002-03-27	Method to culture circovirus

Country Status (24)

Country	Link
US (3)	US6794163B2 (pt)
EP (1)	EP1379671B1 (pt)
JP (1)	JP4038127B2 (pt)
KR (1)	KR100876629B1 (pt)
CN (2)	CN1309836C (pt)
AT (1)	ATE430807T1 (pt)
AU (1)	AU2002244584B2 (pt)
BR (1)	BRPI0208456B8 (pt)
CA (1)	CA2442135C (pt)
CY (1)	CY1109267T1 (pt)
CZ (1)	CZ304525B6 (pt)
DE (1)	DE60232234D1 (pt)
DK (1)	DK1379671T3 (pt)
ES (1)	ES2324466T3 (pt)
HU (1)	HU228065B1 (pt)
MX (1)	MXPA03008810A (pt)
MY (2)	MY148759A (pt)
PL (1)	PL202951B1 (pt)
PT (1)	PT1379671E (pt)
RU (2)	RU2312142C2 (pt)
SK (1)	SK287969B6 (pt)
UA (1)	UA82647C2 (pt)
WO (1)	WO2002077210A2 (pt)
ZA (1)	ZA200307517B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040062775A1 (en) *	1997-12-05	2004-04-01	Agence Francaise De Securite Sanitaire Des Aliments	Circovirus sequences associated with piglet weight loss disease (PWD)
FR2772047B1 (fr) *	1997-12-05	2004-04-09	Ct Nat D Etudes Veterinaires E	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
ES2170622B1 (es) *	1999-12-03	2004-05-16	Consejo Superior De Investigaciones Cientificas	Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
PT1379671E (pt)	2001-03-27	2009-07-20	Univ Saskatchewan	Métodos de cultura de circovírus
US20030096377A1 (en) *	2001-06-28	2003-05-22	Virginia Tech Intellectual Properties, Inc.	Differential PCR-RFLP assay for detecting and distinguishing between nonpathogenic PCV-1 and pathogenic PCV-2
US7279166B2 (en)	2001-12-12	2007-10-09	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en) *	2001-12-12	2007-10-02	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
UA95602C2 (ru)	2004-12-30	2011-08-25	Берингер Ингельхейм Ветмедика, Инк.	Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7700285B1 (en)	2005-12-29	2010-04-20	Boehringer Ingelheim Vetmedica, Inc.	PCV2 immunogenic compositions and methods of producing such compositions
US7833707B2 (en) *	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US8834891B2 (en)	2005-03-14	2014-09-16	Boehringer Ingelheim Vetmedica, Inc.	Immunogenic compositions comprising Lawsonia intracellularis
PT2371383E (pt) *	2005-12-29	2015-11-24	Boehringer Ingelheim Vetmed	Utilização de uma composição imunogénica de pcv2 para atenuar os sintomas clínicos em porcos
MX365868B (es) *	2005-12-29	2019-06-18	Boehringer Ingelheim Vetmedica Inc	Composiciones inmunogenicas de pcv2 multivalentes y metodos de producir composiciones de este tipo.
EP2859900A1 (en)	2006-12-11	2015-04-15	Boehringer Ingelheim Vetmedica, Inc.	Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
HUE044410T2 (hu) *	2006-12-15	2019-10-28	Boehringer Ingelheim Animal Health Usa Inc	Egydózisú anti-PCV2 sertés vakcina
EP1941903A1 (en)	2007-01-03	2008-07-09	Boehringer Ingelheim Vetmedica Gmbh	Prophylaxis and treatment of PRDC
EP1958644A1 (en)	2007-02-13	2008-08-20	Boehringer Ingelheim Vetmedica Gmbh	Prevention and treatment of sub-clinical pcvd
US8518696B2 (en) *	2007-05-11	2013-08-27	Temasek Life Sciences Laboratory Limited	Production of homogeneous cell line highly permissive to porcine circovirus type 2 (PCV2) infection
WO2008151215A1 (en) *	2007-06-04	2008-12-11	Merial Limited	Production of porcine circovirus proteins in plants
US7829274B2 (en) *	2007-09-04	2010-11-09	Boehringer Ingelheim Vetmedica, Inc.	Reduction of concomitant infections in pigs by the use of PCV2 antigen
KR20100094587A (ko) *	2007-12-21	2010-08-26	와이어쓰 엘엘씨	돼지 써코바이러스에 대해 돼지를 면역시키는 방법 및 조성물
CN101932336B (zh) *	2007-12-31	2014-07-09	贝林格尔.英格海姆维特梅迪卡有限公司	有外来氨基酸插入的pcv2 orf2病毒样颗粒
BRPI0907438A2 (pt) *	2008-01-23	2015-08-04	Boehringer Ingelheim Vetmed	Composições imunogênicas para mycoplasma hyopneumoniae e pcv2 e métodos para produzir tais composições
NZ588639A (en) *	2008-04-16	2012-10-26	Virginia Tech Intell Prop	CHIMERIC PORCINE CIRCOVIRUS PCV2Gen-1Rep AND USES THEREOF
AR078253A1 (es) *	2009-09-02	2011-10-26	Boehringer Ingelheim Vetmed	Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
WO2011091389A2 (en) *	2010-01-25	2011-07-28	Blood Systems, Inc.	Cyclovirus and method of use
CA2925281C (en)	2013-09-25	2022-05-03	Zoetis Services Llc	Pcv2b divergent vaccine composition and methods of use
ES2778425T3 (es)	2013-10-02	2020-08-10	Boehringer Ingelheim Animal Health Usa Inc	Variante de la proteína ORF2 del PCV2 y partículas similares a virus compuestas por esta
EP3294876A1 (en)	2015-05-14	2018-03-21	Merial, Inc.	Method for porcine circovirus production and pcv2 vaccines
WO2018071511A1 (en) *	2016-10-11	2018-04-19	Orion Labs	Group communication forwarding to a secondary service
CN114934020B (zh) *	2022-01-30	2024-02-13	山东省滨州畜牧兽医研究院	猪视网膜上皮细胞系及其建立方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20070108418A (ko) *	1996-10-23	2007-11-09	더 트러스티스 오브 더 유니버시티 오브 펜실바니아	면역 치료법 및 개량 백신
AUPO856097A0 (en)	1997-08-14	1997-09-04	Commonwealth Scientific And Industrial Research Organisation	Vector
US6391314B1 (en)	1997-10-03	2002-05-21	Merial	Porcine circoviruses vaccines diagnostic reagents
FR2781159B1 (fr) *	1998-07-06	2000-10-06	Merial Sas	Vaccin circovirus et parvovirus porcin
US7192594B2 (en)	1997-10-03	2007-03-20	Merial Limited	Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
UA78180C2 (uk)	1997-10-03	2007-03-15	Меріаль	Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
US6517843B1 (en) *	1999-08-31	2003-02-11	Merial	Reduction of porcine circovirus-2 viral load with inactivated PCV-2
FR2772047B1 (fr)	1997-12-05	2004-04-09	Ct Nat D Etudes Veterinaires E	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US6287856B1 (en)	1998-03-13	2001-09-11	University Of Georgia Research Foundation, Inc.	Vaccines against circovirus infections
US6492343B1 (en)	1998-04-15	2002-12-10	University Of Saskatchewan	Porcine adenovirus type 3 genome
ATE451378T1 (de)	1998-09-08	2009-12-15	Brij P Giri	Chemolumineszente 1,2-dioxetane
WO2000026395A2 (en)	1998-11-02	2000-05-11	University Of Saskatchewan	Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors
FR2789695B1 (fr)	1999-02-11	2003-03-07	Merial Sas	Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
US6497883B1 (en)	1999-06-10	2002-12-24	Merial	Porcine circovirus recombinant poxvirus vaccine
US6943152B1 (en)	1999-06-10	2005-09-13	Merial	DNA vaccine-PCV
CA2413265A1 (en)	2000-05-03	2001-11-08	University Of Guelph	Porcine adenovirus type 5 vector and vaccine
PT1379671E (pt) *	2001-03-27	2009-07-20	Univ Saskatchewan	Métodos de cultura de circovírus

2002
- 2002-03-27 PT PT02712700T patent/PT1379671E/pt unknown
- 2002-03-27 PL PL364077A patent/PL202951B1/pl unknown
- 2002-03-27 CN CNB02809221XA patent/CN1309836C/zh not_active Expired - Lifetime
- 2002-03-27 AT AT02712700T patent/ATE430807T1/de active
- 2002-03-27 CA CA002442135A patent/CA2442135C/en not_active Expired - Lifetime
- 2002-03-27 UA UA2003109561A patent/UA82647C2/uk unknown
- 2002-03-27 BR BRPI0208456A patent/BRPI0208456B8/pt active IP Right Grant
- 2002-03-27 MY MYPI2011006359A patent/MY148759A/en unknown
- 2002-03-27 DK DK02712700T patent/DK1379671T3/da active
- 2002-03-27 HU HU0500161A patent/HU228065B1/hu unknown
- 2002-03-27 KR KR1020037012491A patent/KR100876629B1/ko active IP Right Grant
- 2002-03-27 MY MYPI20021106A patent/MY146518A/en unknown
- 2002-03-27 JP JP2002576653A patent/JP4038127B2/ja not_active Expired - Lifetime
- 2002-03-27 WO PCT/CA2002/000413 patent/WO2002077210A2/en active Application Filing
- 2002-03-27 AU AU2002244584A patent/AU2002244584B2/en not_active Expired
- 2002-03-27 ES ES02712700T patent/ES2324466T3/es not_active Expired - Lifetime
- 2002-03-27 DE DE60232234T patent/DE60232234D1/de not_active Expired - Lifetime
- 2002-03-27 US US10/112,540 patent/US6794163B2/en not_active Expired - Lifetime
- 2002-03-27 MX MXPA03008810A patent/MXPA03008810A/es active IP Right Grant
- 2002-03-27 SK SK1210-2003A patent/SK287969B6/sk unknown
- 2002-03-27 EP EP02712700A patent/EP1379671B1/en not_active Expired - Lifetime
- 2002-03-27 RU RU2003131342/13A patent/RU2312142C2/ru active
- 2002-03-27 CZ CZ2003-2584A patent/CZ304525B6/cs not_active IP Right Cessation
- 2002-03-27 CN CN2006100731464A patent/CN1840656B/zh not_active Expired - Lifetime
2003
- 2003-09-26 ZA ZA200307517A patent/ZA200307517B/en unknown
2004
- 2004-05-07 US US10/840,879 patent/US7172899B2/en not_active Expired - Lifetime
2007
- 2007-01-17 US US11/654,869 patent/US7560278B2/en not_active Expired - Lifetime
- 2007-03-23 RU RU2007110808/13A patent/RU2007110808A/ru not_active Application Discontinuation
2009
- 2009-08-04 CY CY20091100822T patent/CY1109267T1/el unknown

Also Published As

Publication number	Publication date
KR20040002881A (ko)	2004-01-07
WO2002077210A2 (en)	2002-10-03
SK12102003A3 (sk)	2004-05-04
CA2442135C (en)	2008-08-19
RU2007110808A (ru)	2008-09-27
KR100876629B1 (ko)	2009-01-07
US7560278B2 (en)	2009-07-14
MY148759A (en)	2013-05-31
BRPI0208456B8 (pt)	2021-05-25
WO2002077210A3 (en)	2003-08-21
CN1840656A (zh)	2006-10-04
UA82647C2 (uk)	2008-05-12
CY1109267T1 (el)	2014-07-02
US6794163B2 (en)	2004-09-21
US7172899B2 (en)	2007-02-06
RU2003131342A (ru)	2005-04-20
CZ20032584A3 (en)	2004-03-17
AU2002244584B2 (en)	2006-12-14
EP1379671A2 (en)	2004-01-14
EP1379671B1 (en)	2009-05-06
MXPA03008810A (es)	2004-02-17
RU2312142C2 (ru)	2007-12-10
US20020177216A1 (en)	2002-11-28
HU228065B1 (en)	2012-09-28
CN1840656B (zh)	2010-06-02
ES2324466T3 (es)	2009-08-07
JP2005500822A (ja)	2005-01-13
BR0208456A (pt)	2004-03-02
PT1379671E (pt)	2009-07-20
CA2442135A1 (en)	2002-10-03
CZ304525B6 (cs)	2014-06-18
US20070128700A1 (en)	2007-06-07
CN1309836C (zh)	2007-04-11
HUP0500161A3 (en)	2010-01-28
PL202951B1 (pl)	2009-08-31
DK1379671T3 (da)	2009-06-29
DE60232234D1 (de)	2009-06-18
CN1625598A (zh)	2005-06-08
JP4038127B2 (ja)	2008-01-23
BRPI0208456B1 (pt)	2016-10-18
US20050239187A1 (en)	2005-10-27
HUP0500161A2 (hu)	2005-05-30
ATE430807T1 (de)	2009-05-15
ZA200307517B (en)	2004-09-27
PL364077A1 (en)	2004-12-13
MY146518A (en)	2012-08-15

Publication	Publication Date	Title
SK287969B6 (sk)	2012-08-06	Method to culture circovirus
AU2002244584A1 (en)	2003-03-27	Methods to culture circovirus
US7279166B2 (en)	2007-10-09	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
CN103536911B (zh)	2019-09-13	嵌合传染性dna克隆，嵌合猪环状病毒及其用途
JP2020530761A (ja)	2020-10-29	非ヒト大型類人猿アデノウイルスの核酸配列及びアミノ酸配列、それを含有するベクター、並びにその使用
Pan et al.	2008	Development of recombinant porcine parvovirus-like particles as an antigen carrier formed by the hybrid VP2 protein carrying immunoreactive epitope of porcine circovirus type 2
Huang et al.	2011	Construction and biological characterisation of recombinant porcine circovirus type 2 expressing the V5 epitope tag
KR20100135903A (ko)	2010-12-27	키메라 돼지 써코바이러스 ＰＣＶ２Ｇｅｎ―１Ｒｅｐ 및 이의 용도
Shuai et al.	2011	Functional exchangeability of the nuclear localization signal (NLS) of capsid protein between PCV1 and PCV2 in vitro: Implications for the role of NLS in viral replication
CN100334217C (zh)	2007-08-29	重组鸡马立克氏病病毒转移载体及应用
CN106520833B (zh)	2018-08-28	逃逸哺乳动物血清清除重组杆状病毒疫苗载体的制备方法
Prasetyoa et al.	0	Mutation of the first ATG ORF-3 of Chicken Anemia Virus into ACG completely abolish the apoptin production
AU2012202224A1 (en)	2012-05-10	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof